| Dr Dana Sajed, MD | |
|
1500 San Pablo St, Los Angeles, CA 90033-5313 | |
| (323) 442-9922 | |
| Not Available |
| Full Name | Dr Dana Sajed |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 1500 San Pablo St, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275722126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C148538 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Keck Hospital Of Usc | Los angeles, CA | Hospital |
| Lac+usc Medical Center | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usc Care Medical Group Inc | 0446157747 | 1128 |
News Archive
Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.
Rotech Healthcare Inc. announced today the pricing of its offering of $230 million in aggregate principal amount of Senior Secured Notes due 2015. The notes will be sold to investors at a price of 97.189% of the principal amount thereof and will bear a coupon rate equal to 10 ¾ % per annum. The offering is expected to close on October 6, 2010.
Somanetics Corporation announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to expand features on its Vital Sync bedside monitor and research data aggregation system. The clearance allows for interface with a broader range of bedside devices, display of derived parameters of calculated clinical indices, and an automated events trigger to alert clinicians when patient parameters fall outside desired thresholds.
This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.
› Verified 9 days ago
| Entity Name | Usc Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902846306 PECOS PAC ID: 0446157747 Enrollment ID: O20050512000412 |
News Archive
Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.
Rotech Healthcare Inc. announced today the pricing of its offering of $230 million in aggregate principal amount of Senior Secured Notes due 2015. The notes will be sold to investors at a price of 97.189% of the principal amount thereof and will bear a coupon rate equal to 10 ¾ % per annum. The offering is expected to close on October 6, 2010.
Somanetics Corporation announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to expand features on its Vital Sync bedside monitor and research data aggregation system. The clearance allows for interface with a broader range of bedside devices, display of derived parameters of calculated clinical indices, and an automated events trigger to alert clinicians when patient parameters fall outside desired thresholds.
This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Sajed, MD Po Box 31309, Los Angeles, CA 90031-0309 Ph: (323) 442-9922 | Dr Dana Sajed, MD 1500 San Pablo St, Los Angeles, CA 90033-5313 Ph: (323) 442-9922 |
News Archive
Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.
Rotech Healthcare Inc. announced today the pricing of its offering of $230 million in aggregate principal amount of Senior Secured Notes due 2015. The notes will be sold to investors at a price of 97.189% of the principal amount thereof and will bear a coupon rate equal to 10 ¾ % per annum. The offering is expected to close on October 6, 2010.
Somanetics Corporation announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to expand features on its Vital Sync bedside monitor and research data aggregation system. The clearance allows for interface with a broader range of bedside devices, display of derived parameters of calculated clinical indices, and an automated events trigger to alert clinicians when patient parameters fall outside desired thresholds.
This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.
› Verified 9 days ago
Dr. Tiffany Hackett, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd., Los Angeles, CA 90048 Phone: 310-967-1884 Fax: 310-967-1744 | |
Brennen J. Beatty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Matthew S. Berry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Phillip Gruber, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 N State St, Los Angeles, CA 90033 Phone: 323-226-6667 | |
Daniel Weingrow, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 757 Westwood Plz, Los Angeles, CA 90095 Phone: 310-825-2111 | |
Brian Truong, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 Westwood Blvd, Suite 300, Los Angeles, CA 90095 Phone: 310-794-0585 | |
Emily Michele Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-9922 |